My 3 top dividend stocks for Christmas

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’re reaching the end of the year and looking back on a tumultuous one — who, in January, would have put money on the UK voting to leave the EU and Donald Trump winning the US presidential election? And we’re reconsidering our investment strategies in the light of all that, aren’t we?

The one strategy that will surely win out over the long run is seeking high-quality shares paying big dividends. Here are three that I think would be great homes for any leftover 2016 investment cash.

Pharmaceuticals rebound

AstraZeneca (LSE: AZN) has been beefing up its development pipeline after the expiry of key patents brought an end to some previous blockbusters. And while that’s been underway, the dividend has been held unchanged at an attractive level.

More optimistic investors had been hoping to see a return to EPS growth in 2017, though that’s now looking more like 2018. But flat earnings for 2015 and 2016 are actually better than the falls predicted, and the slow pace of drugs approvals means a pipeline turnaround isn’t an overnight thing.

The weak share price performance of the past two years has put the prospective dividend yield at a healthy 5%, way ahead of the FTSE 100 average. It’s covered by earnings, albeit not strongly, and the company will surely not cut it now, so close to the earnings turnaround point.

AstraZeneca looks like a great buy for progressive future dividends once earnings growth resumes.

Cash from insurance

If you want a cash cow, it’s hard to think of a better one than Admiral Group (LSE: ADM).

The motor insurance firm has been paying special dividends for years, handing out a total of 114.4p per share in 2015 for a yield of 6.9% on the year-end share price. The firm also told us it has distributed at least 90% of each year’s earnings as dividends since flotation, and that this year it will adjust its dividend balance. That means bigger ordinary dividends and smaller specials, with the same overall effect but perhaps lifting confidence a little.

Analysts expect 6.7% this year and 6.8% next, although boosted a little above earnings by the firm’s ongoing return of surplus capital.

Over the longer term, I expect to see total yields of 5% to 6% per year at today’s share price levels, and that’s got to be worth having — especially from a UK-only business that looks safe from Brexit.

Reliable oil

My third pick is good old reliable Royal Dutch Shell (LSE: RDSB) with its consistent dividends all through the oil price crisis. Bob Dudley of BP said we could be in for at least two or three years of cheap oil, which turned out to be right, and his key message was simply not to panic as things would be back to normal over the long term.

And while smaller oil companies, especially those carrying big debts, have suffered, BP and Shell have been largely untroubled.

Earnings at Shell have dropped for four years in a row, and won’t come close to covering this year’s dividend. But Shell has the cash to keep on paying it, and with a couple of years of recovering earnings forecast now that the OPEC agreement is lifting the price of a barrel again, cover should be back next year.

And a dividend yield of 6.4% is one that’s surely not to be missed.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca and Royal Dutch Shell. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

Here’s why I’m staying well clear of Rivian stock

Electric vehicles have excited investors for years now, but can be hit or miss. Here's why Gordon Best will be…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

A 6%+ yield but down 24%! Time for me to buy more of this hidden FTSE 250 gem?

After a rapid share price fall, this FTSE 250 stock's dividend yield has risen, leaving me wondering whether I should…

Read more »

View of Lake District. English countryside with fields in the foreground and a lake and hills behind.
Investing Articles

The United Utilities share price is recovering after mixed earnings report and sewage spill

Is a mild increase in revenue and slightly boosted dividend enough to save the United Utilities share price in light…

Read more »

Dividend Shares

Here’s why the Legal & General share price looks super attractive to me

Jon Smith flags up an important characteristic about the Legal & General share price that makes it appealing to him…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

To aim for £1,000 a month in passive income, should I buy growth shares or value shares?

Deciding which shares are the best to invest in is important when considering long-term passive income. However, there are several…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Here’s why I think AMD stock should be higher

The semiconductor sector has been on a tear lately, but here's why Gordon Best thinks AMD stock still has plenty…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s what investors need to know about the latest Warren Buffett stock

The mystery stock Warren Buffett has been buying has been disclosed to be Chubb – an above-average business at a…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

The Sage share price slides on half-year results: is it time to buy?

Sage’s share price has slipped on an uncertain outlook. But the company’s results suggest it’s still making good progress, says…

Read more »